Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

VYNE VYNE Therapeutics Inc

2,70

-0,03 (-1,10%)

21 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

VYNE Therapeutics (NASDAQ:VYNE)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more VYNE Therapeutics Charts.

VYNE Therapeutics (NASDAQ:VYNE)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more VYNE Therapeutics Charts.

News VYNE Therapeutics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Freitag 1 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Freitag 1 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 29 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Freitag 2 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 3 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 3 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 3 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 3 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 3 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 3 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere VYNE Therapeutics Inc News-Artikel

BMO US Preferred Share I...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen